Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05787548 · ClinicalTrials.gov registry record · NA

Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options

A NA study of Behavior, Health, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
239,841
Enrollment target
1
Study location

NCT05787548: Completed NA study of Behavior, Health, sponsored by Geisinger Clinic.

NCT05787548 is a NA study of Behavior, Health that has completed, run by Geisinger Clinic. The registered enrollment target is 239,841 participants, above the 3,799-participant average among 20 other Behavior, Health trials with a reported enrollment target (6213% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05787548, a NA study of Behavior, Health, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
239,841 participants
Enrollment target
1
Study location

Study Summary

Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care facilities. The study team is working to reduce ED utilization by including additional information in adult outpatient After Visit Summaries (AVSs). The study will involve will involve A/B testing different AVS versions, including 1) a version that encourages patients to contact Geisinger via different contact methods, 2) a version that includes a map to the patient's closest ConvenientCare location and accompanying information about ConvenientCare, and 3) a version that includes a self-triage guide. A control group will receive the current standard AVS. Analysis results will be assessed to determine which version is most effective at reducing ED use.

Primary Outcome

Visited the ED inappropriately (y/n) We will apply the NYU algorithm (Ballard et al., 2010) to determine whether an ED visit is inappropriate.

Conditions Studied

Interventions

  • BEHAVIORAL Contact information
  • BEHAVIORAL Urgent care map
  • BEHAVIORAL Self-triage chart

Study Locations (1)

Pennsylvania

  • Geisinger Clinic - Danville

Trial Details

FieldValue
Enrollment Target 239,841 participants
Start Date 2023-04-03
Est. Completion 2023-12-11
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT05787548 record still lists

NCT05787548 is an interventional study that assigns participants to a tested intervention. Its 239,841 participants enrollment target places it among the larger protocols in the corpus, above the 3,799-participant average among 20 other Behavior, Health trials with a reported enrollment target (6213% higher).

The record links to 1 condition, with Behavior, Health appearing as the primary indexed condition, and to 3 interventions - of which Contact information is the first listed.

NCT05787548 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05787548 about?

NCT05787548 is a clinical study titled "Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options". Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care faci...

What is the current status of trial NCT05787548?

This trial is currently completed. It is a NA study. The enrollment target is 239,841 participants. The study started on 2023-04-03. Estimated completion is 2023-12-11.

What conditions does trial NCT05787548 study?

This clinical trial studies the following conditions: Behavior, Health.

What interventions are being tested in trial NCT05787548?

The interventions under investigation include: Contact information (BEHAVIORAL), Urgent care map (BEHAVIORAL), Self-triage chart (BEHAVIORAL).

Who is sponsoring clinical trial NCT05787548?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05787548 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavior, Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05787548's enrollment target sits among peer trials

239,841 1st of 20 higher than 20 of 20 other Behavior, Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Behavior, Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04735835 · 250,000 participants · NA

    Personalized Responses to Dietary Composition Trial 3

  • NCT06090578 · 180,000 participants · NA

    TabCAT Brain Health Assessment in Primary Care

  • NCT02280733 · 300,000 participants

    A Real-World Registry of Chronic Wounds and Ulcers

  • NCT06694181 · 300,000 participants

    Safe and Explainable AI

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05787548, the US trial registry maintained by the National Library of Medicine. NCT05787548 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.